glp 1 drugs and thyroid cancer GLP-1 Receptor Agonists: A Promising Therapy for Modern Lifestyle Diseases with Unforeseen Challenges Glucagon-like peptide 1 receptor agonist
Description
October 30, 2023
doi: 10.1056/NEJMoa1901118 44 GersteinHCSattarNRosenstockJRamasundarahettigeCPratleyRLopesRDet al
Moreover, evidence from clinical studies is also very promising, enhancing the possibility of adding GLP1-R agonists to the current armamentarium of drugs available for PD treatment
By measuring changes in these marks, the team could assess whether the treatment was associated with a slower or faster biological aging pattern
[PubMed ID: 23581745]
Better Blood Sugar Control For individuals with diabetes, these medications can be a game-changer
